Skip to main content
. Author manuscript; available in PMC: 2015 May 12.
Published in final edited form as: J Am Coll Cardiol. 2014 Mar 5;63(16):1657–1666. doi: 10.1016/j.jacc.2014.02.533

Figure 5. Survival Based on Favorable and Unfavorable CMR Baseline Profiles.

Figure 5

-- Overall survival is markedly better for the 33% of patients (blue) with a favorable CMR profile (CURE < 0.70, no LVLP scar, delayed ECC onset at LVLP) compared with the 31% of patients (red) without dyssynchrony by CURE (CURE ≥ 0.70). The remaining patients (green) had intermediate survival.